Trial Profile
A Long-Term Follow-up Safety Study for Patients with Idiopathic Parkinson's Disease (PD) Implanted with the DDS and/or Who Received Treatment in the Main Study and/or Extension Study
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 May 2020
Price :
$35
*
At a glance
- Drugs HER-096 (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Renishaw
- 24 Aug 2018 New trial record